A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

Blood

Volumn 96, Issue 4, 2000, Pages 1287-1296

  Sainty, D ^a   Liso, V ^a   Cantu Rajnoldi, A ^a   Head, D ^a   Mozziconacci, M J ^a   Arnoulet, C ^a   Benattar, L ^a   Fenu, S ^a   Mancini, M ^a   Duchayne, E ^a   Mahon, F X ^a   Gutierrez, N ^a   Birg, F ^a   Biondi, A ^a   Grimwade, D ^a   Lafage Pochitaloff, M ^a   Hagemeijer, A ^a   Flandrin, G ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; RETINOID;

ACUTE MYELOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; DISEASE CLASSIFICATION; FUSION GENE; GENE EXPRESSION; GENE LOSS; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

DNA-BINDING PROTEINS; GENE REARRANGEMENT; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; ONCOGENE PROTEINS, FUSION; RECEPTORS, RETINOIC ACID; TRANSCRIPTION FACTORS;

EID: 0034663180     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Acute promyelocytic leukaemia
2. Etude de la fibrinolyse au cours des hemopathies malignes. Trans 6(th) Congress Euro Soc Hemato
3. Annexin II and bleeding in acute promyelocytic leukemia
4. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia
5. The unique aspects of acute promyelocytic leukemia
6. Acute promyelocytic leukaemia
7. AIDA (All-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study
8. Differentiation therapy in acute promyelocytic leukemia: European experience
9. Therapy of acute promyelocytic leukemia: All-trans retinoic acid and beyond
10. Proposals for the classification of the acute leukaemias (FAB Co-operative Group)
11. 15/17 Translocation, a consistent chromosomal change in acute promyelocytic leukaemia
12. 'Microgranular' acute promyelocytic leukemia: A distinct clinical, ultrastructural and cytogenetic entity
13. A variant form of acute hypergranular promyelocytic leukaemia (M3)
14. Acute promyelocytic leukaemia: A study of 39 cases with identification of a hyperbasophilic microgranular variant
15. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: Characterization of additional microgranular variants
16. A case of cryptic acute promyelocytic leukemia
17. Acute promyelocytic leukemia toluidine blue subtype
18. Acute promyelocytic leukemia: Morphological aspects
19. A case of acute eosinophilic granulocytic leukemia with PML-RAR alpha fusion gene expression and response to all-trans retinoic acid
20. Identification of the t(15;17) in AML FAB types other than M3: Evaluation of the role of molecular screening for the PML/RARα rearrangement in newly diagnosed AML
21. Immunological definition of acute promyelocytic leukemia (FAB M3): A study of 39 cases
22. Rearrangements of the RAR-α gene in acute promyelocytic leukaemia: Correlations with morphology and immunophenotype
23. The immunophenotype of acute promyelocytic leukemia (APL): An ECOG study
24. CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint
25. Immunophenotype of adult and childhood acute promyelocytic leukaemia: Correlation with morphology, type of PML gone breakpoint and clinical outcome: A cooperative Italian study on 196 cases
26. HLA-DR-, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: A previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3
27. CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?
28. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
29. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia
30. Variant and masked translocations in acute promyelocytic leukemia
31. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party
32. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia
33. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
34. A non-classical translocation involving 17q12 (retinoic acid receptor α) in acute promyelocytic leukemia (APML) with atypical features
35. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin retinoic acid receptor fusion
36. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia
37. A new variant translocation in acute promyelocytic leukemia: Molecular characterization and clinical correlation
38. Fusion of retinoic acid receptor α to NUMA, the nuclear mitotic apparatus protein, by a variant translocation in acute promyelocytic leukaemia
39. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor α in acute promyelocytic-like leukemia
40. Differentiation therapy for acute promyelocytic leukemia
41. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy: Gruppo Italiano-Malattie Ematologiche Maligne dell' Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups
42. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
43. Differentiation of t(5;17) variant acute promyelocytic leukemia blasts by all-trans retinoic acid
44. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient
45. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia
46. Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor
47. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient
48. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia
49. Acute premyelocytic leukaemia with t(11;17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy
50. Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia
51. Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia
52. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): A report on 50 patients
53. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
54. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia
55. RARα-PLZF is a critical determinant of the leukemic phenotype in APL
56. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion: An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations
57. Isolated isochromosome 17q: A distinct type of mixed myeloproferative disorder/myelodysplastic syndrome with an agressive clinical course
58. Chromosome microdissection in leukemia: A powerful tool for the analysis of complex chromosomal rearrangements
59. Acute promyelocytic leukemia with t(11;17)(q23;q21)
60. Localization of the human NCAM gene to band q23 of chromosome 11: The third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11